 Elegant Marbles and Grani Industries Ltd Q2 FY2026 PAT up QoQ at Rs. 1.21 crore
Elegant Marbles and Grani Industries Ltd Q2 FY2026 PAT up QoQ at Rs. 1.21 crore Mahindra Lifespace Developers Ltd Q2 FY2026 consolidated PAT at Rs. 47.90 crores
Mahindra Lifespace Developers Ltd Q2 FY2026 consolidated PAT at Rs. 47.90 crores Zensar Technologies Ltd reports higher consolidated PAT of Rs. 182.2 crores in Q2FY26
Zensar Technologies Ltd reports higher consolidated PAT of Rs. 182.2 crores in Q2FY26 Chemfab Alkalis Ltd consolidated Q2FY26 loss at Rs. 2.01 crore
Chemfab Alkalis Ltd consolidated Q2FY26 loss at Rs. 2.01 crore National Plastic Technologies Ltd Q2 FY2026 PAT increases to Rs. 2.70 crore
National Plastic Technologies Ltd Q2 FY2026 PAT increases to Rs. 2.70 crore 
              Ranbaxy Laboratories Ltd has notified the Bank of New York Mellon (hereinafter "The Bank") to terminate the Deposit Agreements dated July 7, 1994 (under which the Rule 144A Global Depositary Shares / Regulation S Global Depositary Shares have been issued) and underlying GDR programme. The Bank has on October 15, 2014 issued the notice of termination of GDR Programme to the GDR holders and accordingly the Bank will complete the process of termination of GDR programme as per the terms of such notice of termination.
Shares of RANBAXY LABORATORIES LTD. was last trading in BSE at Rs.589.85 as compared to the previous close of Rs. 598.05. The total number of shares traded during the day was 96754 in over 3648 trades.
The stock hit an intraday high of Rs. 605.8 and intraday low of 586.6. The net turnover during the day was Rs. 57855935.